Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Parkinson's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Institute for Neurodegenerative Disorders / XingImaging, LLC, New Haven, Connecticut, United States

    Contact: Study coordinator (Ashley Romano, Clinical Research Nurse II, RN) · info_XI001@xingimaging.com · 475-318-8232
    Contact: Study coordinator (Lydia Currie, Clinical Research Manager) · info_XI001@xingimaging.com · 475-318-8250
    Contact: Principal Investigator (Neha Prakash, MBBS)
Study leads
  • Ken Marek, MD

    Study Chair

    Institute for Neurodegenerative Disorders